The Innovative Development Path And Countermeasures of Biotechnology Drug:Taking Wuhan as an Example
The biopharmaceutical industry that is a subdivision of the modern industrial system urgently requires cultivation and development of new quality productivty.This article reviews the development history and current status of biopharmaceutical industry both domestically and abroad.It meticulously examines the foundational conditions,innovation resources,product innovation dynamics,representa-tive enterprises and industrial chain configurations within Wuhan's biopharmaceutical sector,emplo-ying a methodology that integrates literature research,field investigations,and data analysis.Conse-quently,it illuminates the internal and external challenges confronting Wuhan's biopharmaceutical in-dustry.Wuhan boasts a unique geographical location,abundant educational,scientific,and medical re-sources,along with strengths in information technology.Nonetheless,in its developmental course,the city encounters issues such as a low level of development capacity,small industrial scale,inefficient technology transfer,and inadequate policy support.Drawing upon the conceptual framework of"Five Chains"-innovation chain,industrial chain,talent chain,capital chain,and policy chain-the article pro-poses considerations and recommendations for optimizing the allocation of industrial elements.This ap-proach aims to enhance the development capacity of biopharmaceutical industry,thereby furnishing strategic insights and guidelines for its ascension.